Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀåÀº 2025³â 37¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È CAGR 8.1%¸¦ ³ªÅ¸³»¸ç 2032³â¿¡´Â 65¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛÀ̶ó´Â ÀǾàǰ Æ÷Àå ±â¼úÀº ´ÜÀÏ ¿ë±â¿¡ ¿©·¯ ¹ø ¾à¹°À» ³Ö±â À§ÇØ ¸¸µé¾îÁý´Ï´Ù. ƯÈ÷ ¸¸¼º Áúȯ ȯÀÚ, º´¿ø ¹× º¹Áö ½Ã¼³°ú °°Àº ȯ°æ¿¡¼ º¹¿ë ¾îµåÈ÷¾î·±½º¸¦ ³ôÀÌ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº ³¯Â¥¿Í ½Ã°£¿¡ µû¶ó º¹¿ë·®À» ¹èÄ¡ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ Åõ¾à ´©ÃâÀ̳ª Åõ¾à ½Ç¼öÀÇ °¡´É¼ºÀÌ ³·¾ÆÁý´Ï´Ù. º´, ¹°Áý ÆÑ, ÆÄ¿ìÄ¡ µîÀÇ ÇüÅ·ΠÁ¦°øµÇ¹Ç·Î ¸ð´ÏÅ͸µ°ú Á¦Á¦°¡ °£¼Òȵ˴ϴÙ. ¶ÇÇÑ ´Ùȸ Åõ¾à Æ÷ÀåÀº ¾ÈÀü¼º, Æí¸®¼º ¹× È¿À²¼ºÀ» Çâ»ó½ÃŰ¸é¼ ¾à¹° Åõ¿© ¹× °ü¸®¿¡¼ ³¶ºñ¿Í ½Ç¼ö¸¦ ÁÙ¿©ÁÝ´Ï´Ù.
º¹¾à Áؼö¿Í ÆíÀǼº¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
Àß Á¤¸®µÇ°í ¶óº§ÀÌ ºÙÀº Æ÷ÀåÀº ȯÀÚ, ƯÈ÷ ³ëÀΰú Àå±â ÁúȯÀ» °¡Áø ȯÀÚ¿¡°Ô À¯¿ëÇÕ´Ï´Ù. Á¤È®ÇÏ°í ½Ã±â ÀûÀýÇÑ º¹¿ëÀ» º¸ÀåÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¹æ¹ýÀº ÀǾàǰ ½Ç¼ö¸¦ ÁÙÀÔ´Ï´Ù. ȯÀÚ º¹¿ë ±ÔÁ¤ Áؼö¸¦ °³¼±Çϱâ À§ÇØ °£º´Àΰú ÀÇ·á Àü¹®°¡´Â ¿©·¯ ¹ø Åõ¿©ÇÒ ¼ö ÀÖ´Â Æ÷ÀåÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ¼ºñ½ºÀÇ Ç°Áú°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¾à±¹¿¡¼ äÅõǴ ºóµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ´Â °ÍÀº ¾à¹° Åõ¿©¿¡ ÀÖ¾î¼ Á¤È®¼º°ú È¿À²¼ºÀÇ ¿ä±¸ÀÔ´Ï´Ù.
³ôÀº Ãʱâ ÅõÀÚ ¹× ¿î¿µ ºñ¿ë
Áß¼Ò±Ô¸ð ¾à±¹¿¡¼´Â ÀÚµ¿ Æ÷Àå Àåºñ¸¦ ¼³Ä¡ÇÏ´Â µ¥ ÇÊ¿äÇÑ ¸¹Àº ºñ¿ëÀ» Àý°¨ÇϱⰡ ¾î·Æ½À´Ï´Ù. ¿î¿µ ºñ¿ëÀº À¯Áö º¸¼ö ¹× Á÷¿ø ±³À°À¸·Î ´õ¿í Áõ°¡ÇÕ´Ï´Ù. ¸¹Àº °Ç° °ü¸® °³¾÷ÀǵéÀº ºñ¿ëÀÌ ¸¹ÀÌ µé±â ¶§¹®¿¡ ±âÁ¸ÀÇ Æ÷Àå ¹æ¹ýÀ» ¹ö¸®´Â °ÍÀ» ¸Á¼³À̰í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î °æÁ¦Àû Àå¾Ö´Â ÀÌ·¯ÇÑ ÃÖ÷´Ü ¼Ö·ç¼ÇÀÌ ³Î¸® äÅõǴ °ÍÀ» ¹æÇØÇÕ´Ï´Ù.
½º¸¶Æ® ±â¼ú ¹× µðÁöÅÐ °Ç° Ç÷§Æû°úÀÇ ÅëÇÕ
ÀÚµ¿ ¾Ë¸² ¹× ½Ç½Ã°£ ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÌ·¯ÇÑ ±â¼úÀº Åõ¿© ´©Ãâ°ú Åõ¿© ½Ç¼öÀÇ °¡´É¼ºÀ» °¨¼Ò½Ãŵ´Ï´Ù. ÇコÄÉ¾î ´ã´çÀÚ´Â ½º¸¶Æ® Æ÷Àå ¼Ö·ç¼ÇÀ» ÅëÇØ »ç¿ë µ¥ÀÌÅ͸¦ ¹ÞÀ» ¼ö ÀÖ¾î º¸´Ù È¿°úÀûÀÎ ¸ð´ÏÅ͸µ°ú °³º° Ä¡·á ¼öÁ¤ÀÌ °¡´ÉÇÕ´Ï´Ù. °ø±Þ¸ÁÀÇ È¿À²¼º°ú Àç°í °ü¸®´Â µðÁöÅÐ ¿¬°áÀ» ÅëÇØ ´õ¿í °ÈµË´Ï´Ù. ¿ø°Ý ÀǷḦ Áö¿øÇÏ´Â Áö´ÉÇü Æ÷ÀåÀÇ ¿ä±¸´Â ¿ø°Ý ÀÇ·á »ç¿ëÀÇ È®´ë·Î ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÀǾàǰÀÇ À¯Åë ¹æ¹ýÀ» Çö´ëÈÇÕ´Ï´Ù.
¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ ¹× Æ÷Àå Æó±â¹° ¿ì·Á
Á¦Ç° °³¹ßÀº ±â¾÷ÀÌ ¾ö°ÝÇÑ Ç¥½Ã, Àç·á ¾ÈÀü ¹× ¿ë·® Á¤È®µµ ±ÔÁ¤À» ÁؼöÇØ¾ß ÇÏ´Â Çʿ信 µû¶ó Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ Æ÷Àå ÇüÅÂÀÇ Àû½Ã µµÀÔµµ ±ÔÁ¦ Áö¿¬¿¡ ÀÇÇØ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Æ÷Àå Æó±â¹°¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö°í Àֱ⠶§¹®¿¡ ±â¾÷Àº Áö¼Ó °¡´ÉÇÑ Àç·á¿¡ ´ëÇÑ ÅõÀÚ¸¦ °¿äÇϰí ÀÖÀ¸¸ç Á¦Á¶ ºñ¿ëÀÌ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ´ÙÁß ¿ë·® Æ÷Àå ¼³°è´Â ¸¹Àº Àå¼Ò¿¡¼ ÀçȰ¿ë ¹× Æó±â¿¡ °üÇÑ ±ÔÁ¦ÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿ä¼Ò°¡ °áÇÕµÇ¾î ¼öÀͼºÀ» ³·Ãß°í »õ·Î¿î °æÀïÀ» ¾ïÁ¦ÇÕ´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19ÀÇ ´ëÀ¯ÇàÀº ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¾à¹° Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦»ê¾÷ü´Â »ç¶÷°úÀÇ Á¢ÃËÀ» ÃÖ¼ÒÈÇÏ°í ¿À¿° À§ÇèÀ» ÁÙÀÌ´Â Æ÷Àå ¼Ö·ç¼ÇÀ» ã°í º´¿ø ¹× ¾à±¹¿¡¼ ´Ùȸ Åõ¾à ½Ã½ºÅÛÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. °ø±Þ¸Á È¥¶õ°ú ¿øÀç·á ºÎÁ·À¸·Î ÀÎÇØ óÀ½¿¡´Â »ý»êÀÌ Áö¿¬µÇ¾úÁö¸¸ ¾ÈÀüÇϰí Á¶Á÷ÀûÀÎ Åõ¾àÀÌ ½Ã±ÞÇ߱⠶§¹®¿¡ ±â¼ú Çõ½Å°ú ÀÚµ¿È¿¡ ´ëÇÑ ÅõÀÚ°¡ ÃËÁøµÇ¾ú½À´Ï´Ù. ÆÒµ¥¹ÍÀº ¶ÇÇÑ È¯ÀÚÀÇ º¹¾à Ãæ°í¿Í ¾ÈÀü¼ºÀÇ Á߿伺À» °Á¶ÇÏ°í ¼¼°è °Ç° °ü¸® ½Ã½ºÅÛ ½ÃÀå °ü·Ã¼ºÀ» ´õ¿í °ÈÇß½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È º´ ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á
º´ ºÎ¹®Àº ÀǾàǰ ¹× °Ç° °ü¸®¿¡¼ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º´Àº Á¤È®ÇÑ Åõ¿©, Àç¹ÐºÀ¼º, ¿À¿°À¸·ÎºÎÅÍ º¸È£¸¦ Á¦°øÇϸç, ´Ù¿ëµµ ¿ëµµ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ´Ù¾çÇÑ ¾×ü ¹× °íü Á¦Á¦¿ÍÀÇ È£È¯¼ºÀÌ ½ÃÀå äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó º´¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´ µðÀÚÀΰú Áö¼Ó °¡´ÉÇÑ ¼ÒÀçÀÇ Áøº¸°¡ ½ÃÀå Á¡À¯À² È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.
¿¹Ãø±â°£ µ¿¾È °£È£½Ã¼³ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È, ÀϰüµÈ Åõ¾à °ü¸®¸¦ ÇÊ¿ä·Î ÇÏ´Â ³ëÀÎ Àα¸ Áõ°¡´Â °£º´ ½Ã¼³ ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³¿¡¼´Â ¾à¹° Åõ¿©ÀÇ ¾ÈÀü¼º°ú Á¤È®¼ºÀÌ ¿ì¼±Çϱ⠶§¹®¿¡ ´ÙÁß µµÁî Æ÷ÀåÀº Åõ¾à ½Ç¼ö¸¦ ÁÙÀÓÀ¸·Î½á À̸¦ Áö¿øÇÕ´Ï´Ù. »çÀü Æ÷ÀåµÈ ¿ë·®Àº ½Ã°£À» Àý¾àÇϰí Á¦Á¦ °øÁ¤À» °£¼ÒÈÇÏ¿© Á÷¿øÀÇ È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ±ÔÁ¦±â°üÀÌ °£º´ ÇöÀå¿¡¼ÀÇ º¹¾à Áؼö¸¦ Áß½ÃÇÔ¿¡ µû¶ó, ÄÄÇöóÀ̾𽺠Æ÷Àå ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, Àå±â °£È£ ½Ã¼³Àº ´Ùȸ Åõ¾à Æ÷Àå ½Ã½ºÅÛ Ã¤¿ëÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡ ¹× °Ç° °ü¸® ÀÎÇÁ¶ó È®´ë·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, ÀϺ», Àεµ µî ±¹°¡µéÀº ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ °ÈÇϰí Åõ¾à ½Ç¼ö¸¦ ÁÙÀ̱â À§ÇØ °í±Þ ÀǾàǰ Æ÷Àå ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ¿Í µðÁöÅÐ ÇコÀÇ µµÀÔ°ú ÇÔ²², ½º¸¶Æ®ÇÑ Åõ¾à °ü¸®¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡°¡ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇöÁö ±â¾÷Àº º´¿ø ¹× ÀçÅà Äɾî ȯ°æ¿¡¼ÀÇ ¿ä±¸ Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ºñ¿ë È¿À²ÀûÀ̰í Áö¼Ó °¡´ÉÇÑ Æ÷Àå ¼Ö·ç¼ÇÀ¸·Î Àû±ØÀûÀ¸·Î ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇß½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ÀÌ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, ¼±ÁøÀûÀÎ ¾à»ç °üÇà, Á¦Á¦¿¡¼ ÀÚµ¿ÈÀÇ °·ÂÇÑ Ã¤¿ëÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â Çõ½ÅÀûÀÎ ºí¸®½ºÅÍ ÆÑ°ú RFID Áö¿ø Æ÷ÀåÀ» ÅëÇØ ÀǾàǰ Áؼö¸¦ ÃÖ¼ÒÈÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í Àå±â °£È£ ½Ã¼³, ¾ç·Î¿ø, ¿Ü·¡ ȯÀÚ ¼ºñ½º ¼ö¿ä Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ¹× µðÁöÅРó¹æ Ç÷§Æû°úÀÇ ÅëÇÕÀÌ º¸±ÞµÇ°í ÀÖÀ¸¸ç, ´Ùȸ Åõ¾à Æ÷ÀåÀº ¾÷¹« È¿À²¼º°ú ȯÀÚ °á°ú °³¼±¿¡ ÇʼöÀûÀÔ´Ï´Ù.
According to Stratistics MRC, the Global Multi-Dose Packaging System Market is accounted for $3.7 billion in 2025 and is expected to reach $6.5 billion by 2032 growing at a CAGR of 8.1% during the forecast period. A pharmaceutical packaging technique called a multi-dose packaging system is made to include several doses of medication in one container. It is frequently used to increase drug adherence, especially for patients with chronic diseases and in environments like hospitals and assisted living facilities. These methods frequently arrange dosages according to date and time, which lowers the possibility of missing or giving the wrong dosage. Available in bottles, blister packs, or pouches, they simplify monitoring and dispensing. Additionally, multi-dose packaging reduces waste and mistakes in the administration and management of medications while improving safety, convenience, and efficiency.
Rising demand for medication adherence and convenience
Well-organised and labelled packaging is beneficial to patients, particularly the elderly and those with long-term illnesses. By guaranteeing precise and timely dosage, these methods lower pharmaceutical mistakes. For better patient compliance, carers and medical professionals favour multi-dose packs. These solutions are being adopted by pharmacies more frequently in an effort to improve service quality and safety. In general, market expansion is driven by the requirement for accuracy and efficiency in drug administration.
High initial investment and operational costs
Small and mid-sized pharmacies may find it difficult to afford the significant expenditure needed to set up automated packaging equipment. Operational costs are further increased by maintenance and employee training. Many healthcare practitioners are discouraged from abandoning traditional packing methods because to the hefty expenses. Consequently, there is still little market penetration, particularly in underdeveloped nations. Overall, financial obstacles prevent these cutting-edge solutions from being widely adopted.
Integration with smart technologies and digital health platforms
The chance of missing or giving the wrong dose is decreased by these technologies, which allow for automated reminders and real-time tracking. Healthcare practitioners can receive usage data via smart packaging solutions, enabling more effective monitoring and individualised treatment modifications. The efficiency of the supply chain and inventory management are further enhanced by digital connectivity. The need for intelligent packaging that supports remote care is further increased by the expanding use of telemedicine. All things considered, these developments enhance patient outcomes and modernise medication distribution methods.
Strict regulatory standards and packaging waste concerns
Product development may be slowed down by the need for businesses to adhere to strict labelling, material safety, and dosage precision regulations. The timely introduction of innovative packaging formats may also be impacted by regulatory delays. Furthermore, companies are being forced to invest in sustainable materials due to increased worries about packaging waste, which raises production costs. Existing multi-dose packaging designs are challenged by recycling and disposal regulations in many places. All of these elements work together to lower profitability and deter new competitors.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the Multi-Dose Packaging System Market by increasing demand for secure and efficient medication dispensing. Healthcare providers sought packaging solutions that minimized human contact and reduced the risk of contamination, driving the adoption of multi-dose systems in hospitals and pharmacies. Supply chain disruptions and raw material shortages initially slowed production, but the urgent need for safe, organized medication delivery fuelled innovation and investments in automation. The pandemic also emphasized the importance of patient adherence and safety, further strengthening the market's relevance in global healthcare systems.
The bottles segment is expected to be the largest during the forecast period
The bottles segment is expected to account for the largest market share during the forecast period, due to its widespread use in pharmaceuticals and healthcare. Bottles offer precise dosing, resealability, and protection from contamination, making them ideal for multi-use applications. Their compatibility with various liquid and solid formulations enhances market adoption. Growing demand for user-friendly and cost-effective packaging solutions boosts their preference. Additionally, advancements in bottle design and sustainable materials support their increasing market share.
The long-term care facilities segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the long-term care facilities segment is predicted to witness the highest growth rate, due to the rising elderly population requiring consistent medication management. These facilities prioritize safety and accuracy in drug administration, which multi-dose packaging supports by reducing medication errors. Staff efficiency improves as pre-packaged doses save time and streamlines dispensing processes. The demand for compliance packaging grows as regulatory bodies emphasize adherence in care settings. Consequently, long-term care facilities drive sustained growth in the adoption of multi-dose packaging systems.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising geriatric population, increasing prevalence of chronic diseases, and expanding healthcare infrastructure. Countries like China, Japan, and India are investing in advanced pharmaceutical packaging technologies to enhance patient compliance and reduce medication errors. Growing awareness of smart medication management, along with rapid urbanization and digital health adoption, further fuels demand. Local players are actively innovating with cost-effective and sustainable packaging solutions to cater to the rising need in hospital and homecare settings.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by stringent regulatory standards, advanced pharmaceutical practices, and strong adoption of automation in drug dispensing. The U.S. and Canada are focusing on minimizing medication non-adherence through innovative blister packs and RFID-enabled packaging. The presence of key market players and growing demand from long-term care facilities, nursing homes, and outpatient services amplify market expansion. Integration with electronic health records (EHRs) and digital prescription platforms are gaining traction, making multi-dose packaging essential for operational efficiency and improved patient outcomes.
Key players in the market
Some of the key players profiled in the Multi-Dose Packaging System Market include Omnicell, Inc., Swisslog Healthcare, Tosho Co., Ltd., Manrex Limited, Becton, Dickinson and Company (BD), McKesson Corporation, Cardinal Health, Inc., Baxter International Inc., Parata Systems, LLC, ScriptPro LLC, Yuyama Co., Ltd., ARxIUM Inc., JVM Co., Ltd., Accu-Chart Plus Healthcare Systems, Inc. and Euclid Medical Products.
In May 2025, Tosho unveiled enhanced specifications for the Xana 4001U2 Advance, a high-capacity full-automatic tablet packing system. Updates included improved drug recognition accuracy, faster multi-dose dispensing, and streamlined user interface for hospital and pharmacy operations, boosting productivity while maintaining strict medication safety and traceability standards.
In May 2025, Omnicell launched a new line of RFID-enabled products called MedTrack. These are designed for perioperative and clinic settings, offering advanced automation, intelligent software workflows, and enhanced medication inventory management. The platform aims to reduce medication errors and streamline multi-dose packaging processes through automated tracking and inventory control.
In April 2025, Swisslog Healthcare's AutoPack(TM) upgrades with the U Canister and Variable Heater enhance packaging flexibility and efficiency. The U Canister holds up to 280 tablets, including irregular sizes, while the Variable Heater supports customizable package lengths (50-95 mm), streamlining cartfill and ADU workflows-crucial for addressing staff shortages and optimizing multi-dose medication delivery.